Phase 2 N=31 NeuroCognition After Carotid Recanalization
Cognition Disorder · Stroke · Occlusion Carotid
Primary: Change in Montreal Cognitive Assessment (MoCA) Score — 0.56; 1.38; -0.75; 0.50 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=451 Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis
Ischemic Stroke
Primary: Any Stroke or Death Within 30 Days of Enrollment or Any Revascularization Procedure OR an Ischemic Stroke in the Territory of the Symptomatic Intracranial Artery Beyond…
N/A N=129 Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis
Carotid Stenosis
Primary: Radical Peripapillary Capillaries Vessel Density — 55.95; 57.24 percentage of vessel
N/A N=52 Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis
Intracranial Arterial Stenosis · Intracranial Atherosclerosis · Ischemic Stroke
Primary: Stroke or Death in the Territory of Qualifying Artery — 5 Participants — p=0.08
N/A N=2,502 Carotid Revascularization Endarterectomy Versus Stenting Trial
Atherosclerosis · Stroke · Carotid Stenosis
Primary: Any Periprocedural Stroke, Myocardial Infarction, or Death During a 30-day Peri-procedural Period, and Postprocedural Ipsilateral Stroke Thereafter, up to 4-years…
Phase 4 N=457 Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
Cerebral Infarction · Atherosclerosis
Primary: Number of Participants With Progression of Symptomatic Intracranial Stenosis — 20; 32 participants
N/A N=40 Effects of Carotid Stent Design on Cerebral Embolization
Stroke · Carotid Stenosis
Primary: Transcranial Doppler Counts of Micro-embolic Signals in the Ipsilateral Middle Cerebral Artery. — 264; 339 Micro-emboli
N/A N=170 Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
Cognitive Manifestations
Primary: Composite Cognitive Score — 45.5; 47.9 units on a scale
N/A N=322 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)
Carotid Artery Disease
Primary: Kaplan-Meier Estimate of Freedom From the Composite of Any Death, Stroke and MI During the 30 Day Post Procedural Period (DSMI), Plus Fatal and Non-fatal Ipsilateral…
Phase 3 N=486 ViVEXX Carotid Revascularization Trial (VIVA)
Carotid Artery Stenosis
Primary: Percentage of Patients Experiencing Major Adverse Events (MAE) — 6.9 percentage of participants
N/A N=75 Silk Road Medical First in Man Study - Neuroprotection During Carotid Stenting and Angioplasty
Carotid Artery Diseases
Primary: Safety Evaluation as Composite of Occurrences of Major Stroke, Myocardial Infarction and Death — 0; 0; 0 Occurences
N/A N=120 The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms
Wide-neck, Saccular Intracranial Aneurysms
Primary: Number of Participants With Raymond Class I Complete Obliteration at 12 Months — 98 Participants
N/A N=230 Additional Neurological Symptoms Before Surgery of the Carotid Arteries - A Prospective Study (ANSYSCAP)
Carotid Stenoses
Primary: Ipsilateral Ischemic Stroke Before Carotid Endarterectomy — 33 participants
Phase 3 N=219 Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
Carotid Artery Disease
Primary: Hierarchical Composite of Stroke, Myocardial Infarction, and Death — 8 Participants
Phase 1 N=20 A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries
Atherosclerosis · Aneurysm
Primary: Technical Feasibility- Successful Stent/Coil Placement (Post Procedure) — 100; 90 percentage of stable placement
Early Phase 1 N=453 Endovascular Recanalization and Standard Medical Management for Symptomatic Nonacute Intracranial Artery Occlusion Trial
Intracranial Artery Occlusion With Infarction
Primary: Primary Outcome — 27; 21 Participants
N/A N=2 Pilot Study of Pre-Ischemic Conditioning for Intracranial Atherosclerosis
Intracranial Atherosclerosis
Primary: Percent Change in Cerebral Blood Flow (CBF) — 0; 25 percentage increase in CBF
Phase 4 N=114 Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting
CVD
Primary: Number of Participants With Occlusion and Restenosis at One Year — 58; 56 participants
N/A N=82 An International Registry of the Wingspan™ Stent System for the Treatment of Intracranial Atherosclerotic Stenosis
Intracranial Atherosclerosis
Primary: Successful Wingspan™ Stent Implantation (Access to the Lesion With the Stent, Accurate Deployment of the Stent Across the Target Lesion) — 78 patients w stent implanted
Phase 3 N=242 SONOlysis in Prevention of Brain Infarctions dUring Carotid Stenting and caroTid EndaRterectomy
Internal Carotid Artery Stenosis
Primary: Participants With a New Brain Infarction Detected Using Magnetic Resonance — 5; 15; 33; 42 participants
N/A N=55 The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation
Carotid Artery Diseases · Carotid Atherosclerosis · Carotid Stenosis
Primary: Incidence of Ipsilateral New White Lesions, by Patient — 12 Participants
N/A N=1,500 Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study
Carotid Artery Disease
Primary: Composite Rate of Death, Ipsilateral CVA, Procedure-related CVA, or Myocardial Infarction (MI) at 30 Days Post-procedure. — 99 participants
Phase 4 N=217 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
Coronary Artery Disease · Carotid Artery Diseases · Atherosclerosis
Primary: Annualized LRNC Volume Change in Carotid Plaque Composition, as Assessed by MRI — -4.6; -15.1; -9.4 mm^3/year
Phase 2 N=189 Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting
Carotid Artery Stenosis
Primary: Number of Patients With Cerebrovascular Events, Cardiovascular Events or Death. — 0; 2; 2; 1 participants
N/A N=312 The Gore SCAFFOLD Clinical Study
Carotid Artery Disease · Carotid Artery Stenosis
Primary: Number of Participants Who Experienced Major Adverse Events (MAE) at One Year — 11 Participants — p=<0.00001
N/A N=817 Neuropsychometric Outcome After Carotid Endarterectomy
Carotid Artery Stenosis · Carotid Artery Disease · Transient Ischemic Attack
Primary: Percentage of Patients Having a Significant Change in Neuropsychometric Performance After Carotid Endarterectomy — 22; 4.5 percentage of participants
Phase 3 N=947 Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Atherosclerosis · Cardiovascular Diseases · Hypertension, Renovascular
Primary: Composite Endpoint: Death From Cardiovascular or Renal Causes, Stroke, Myocardial Infarction, Hospitalization for CHF, Progressive Renal Insufficiency, or Permanent…
Phase 3 N=250 GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)
Carotid Artery Stenosis
Primary: Composite Major Adverse Event (MAE) Rate of Death, Myocardial Infarction, and Stroke at 30 Days Postprocedure — 10; 2; 1; 0 Participants — p=0.0001
Phase 2 N=6 TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study
Carotid Arteries
Primary: Uptake of [F-18] RGD-K5 by Carotid Plaque With PET/MRI Imaging in the Artery Believed to be the Cause of Transient Ischemic Attack (TIA) or Stroke Symptoms Compared to…
N/A N=125 Non-invasive Computer-Aided Phenotyping of Vasculopathy
Carotid Atherosclerosis · Peripheral Arterial Disease
Primary: Measurement Bias of Calcification Analyzed by vascuCAP™ Non-invasively Relative to Histopathology as Ground Truth. — -0.47; .07 mm2